These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33627075)

  • 1. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.
    Demers AM; Kim S; McCallum S; Eisenach K; Hughes M; Naini L; Mendoza-Ticona A; Pradhan N; Narunsky K; Poongulali S; Badal-Faesen S; Upton C; Smith E; Shah NS; Churchyard G; Gupta A; Hesseling A; Swindells S;
    BMC Infect Dis; 2021 Feb; 21(1):205. PubMed ID: 33627075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
    Hanrahan CF; Dorman SE; Erasmus L; Koornhof H; Coetzee G; Golub JE
    PLoS One; 2012; 7(11):e49898. PubMed ID: 23226229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh.
    Mishra M; Pandey A; Chaturvedi P; Chaudhary E; Bisht AS
    Indian J Tuberc; 2024; 71 Suppl 1():S77-S80. PubMed ID: 39067960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
    PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
    Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
    Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
    Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
    Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
    PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].
    Nosova EIu; Krasnova MA; Galkina KIu; Makarova MV; Litvinov VI; Moroz AM
    Mol Biol (Mosk); 2013; 47(2):267-74. PubMed ID: 23808160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
    Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
    Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.